Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
Clinical trial NCT04848506 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04848506
- Sponsor
- Cytokinetics
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2028-03-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.